EVMN Operating Cash Flow (Statement)

Evommune, Inc. Common Stock · Operating Cash Flow (Statement)

EVMN logo

EVMN Operating Cash Flow (Statement)

Latest reported-$74.15M
EVMN Cash from Operations (-$29.97M → -$74.15M)
High-resolution chart · PNG

EVMN operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Evommune, Inc. Common Stock Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-76,441,000
-58,195,000
-29,970,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.